Goberna María Florencia, Whelan Agustina Inés, Godoy Perla, Lewi Dalia Marcela
National Directorate of Bioeconomy, Secretariat of Food, Bioeconomy and Regional Development, MAGyP, Buenos Aires, Argentina.
Front Bioeng Biotechnol. 2022 Feb 21;10:835378. doi: 10.3389/fbioe.2022.835378. eCollection 2022.
Argentina currently has a regulation for genome-editing products whose criteria were updated as consultations were received to determine the regulatory status of these products. The aim of this regulation is to consider all organisms (animals, micro-organisms and plants) under the same NBT resolution independently and without being linked to commercial Genetically Modified Organism (GMO) regulations. This gives certainty to local researchers and developers (teams of local developers and researchers), which can be seen in the number of developments and consultations carried out. It should be noted that early results showed that the speed of innovation of these technologies was increasing in a short time, giving more opportunity to local developers who showed interest in generating products in different species, crops and phenotypes.
阿根廷目前对基因组编辑产品有一项规定,随着收到相关咨询以确定这些产品的监管状态,其标准也得到了更新。该规定的目的是独立地、不与商业转基因生物(GMO)法规挂钩,在同一新兴生物技术决议下考虑所有生物(动物、微生物和植物)。这为当地研究人员和开发者(当地开发者和研究人员团队)提供了确定性,这一点从开展的研发和咨询数量中可见一斑。应该指出的是,早期结果表明,这些技术的创新速度在短时间内不断加快,为有兴趣在不同物种作物和表型中开发产品的当地开发者提供了更多机会。